Coming soon: blood tests to help detect early Alzheimer’s disease
Date: 2021-04-16Researchers are confident that it will soon be possible to do blood tests to see if there are signs of early Alzheimer's already.
The researchers, including Professor Henrik Zetterberg, with whom Alzinova is collaborating to track markers of neurodegenerative change in Alzheimer’s disease, have studied the accuracy of blood tests compared to current detection methods, such as measuring spinal fluid or MRI/PET brain imaging.
“It turns out that the blood test correlates 90 percent correctly,” says Henrik Zetterberg, professor in neurochemistry at Sahlgrenska University Hospital.
“Besides facilitating earlier detection of Alzheimer’s patients, biomarker blood tests could also be useful in clinical studies to reduce timelines and speed up the time to market for disease modifying treatments that can benefit patients,” says Kristina Torfgård, CEO, Alzinova.
Alzinova’s collaboration with Professor Henrik Zetterberg focuses on measuring and evaluating potential changes in biomarkers associated with Alzheimer’s disease and/or neurodegeneration following multiple immunisations with the therapeutic vaccine ALZ-101 in an upcoming clinical Phase 1b study with participants with early Alzheimer’s disease.